Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02141282 |
|---|---|
| Brief Title: | A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy |
| First Submitted : | May 12, 2014 |
| First Submitted that Met QC Criteria : | May 15, 2014 |
| First Posted : | May 19, 2014 (Estimate) |
| Results First Submitted : | November 18, 2022 |
| Results First Submitted that Met QC Criteria : | November 18, 2022 |
| Results First Posted : | December 19, 2022 |
| Last Update Submitted that Met QC Criteria : | November 18, 2022 |
| Last Update Posted : | December 19, 2022 |